Cite
Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)
MLA
Patrik Oleksak, et al. “Contemporary MTOR Inhibitor Scaffolds to Diseases Breakdown: A Patent Review (2015-2021).” European Journal of Medicinal Chemistry, vol. 238, Mar. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9d5a140d644035590d95b9c2339f9a3f&authtype=sso&custid=ns315887.
APA
Patrik Oleksak, Eugenie Nepovimova, Zofia Chrienova, Kamil Musilek, Jiri Patocka, & Kamil Kuca. (2022). Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021). European Journal of Medicinal Chemistry, 238.
Chicago
Patrik Oleksak, Eugenie Nepovimova, Zofia Chrienova, Kamil Musilek, Jiri Patocka, and Kamil Kuca. 2022. “Contemporary MTOR Inhibitor Scaffolds to Diseases Breakdown: A Patent Review (2015-2021).” European Journal of Medicinal Chemistry 238 (March). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9d5a140d644035590d95b9c2339f9a3f&authtype=sso&custid=ns315887.